A Rocambolesque Metafiction

Excerpt

I respectfully disagree with most comments elucidated by Musella et al. [1] Interestingly, a recent presentation during the latest ASMBS annual meeting in Nashville on November 15 by Dr Maud Robert and co-authors presented a level 1 evidence comparing one-anastomosis gastric bypass, OAGB, versus Roux-en-Y gastric bypass, RYGB [2]. The strength of this trial is reflected on the fact that it is a multicentric randomized controlled trial of non-inferiority, with OAGB performed according to the majority of those who are proponents, and the RYGB performed the classical way, all laparoscopically, from high volume centers in France. Both groups had 128 patients followed up to 2 years, with the same indications according to NIH criteria, excluding severe GERD, Barrett’s esophagus, and/or esophagitis. Baseline characteristics were similar. …